Abstract

Cardiovascular diseases (CVDs), including thrombosis, which is induced by platelet aggregation, are the leading cause of mortality worldwide. The P2Y1 receptor (P2Y1R) facilitates platelet aggregation and is thus an important potential anti-thrombotic drug target. The P2Y1R protein structure contains a binding site for receptor antagonist MRS2500 within its seven-transmembrane bundle, which also provides suitable pockets for numerous other ligands to act as nucleotide antagonists of P2Y1R. The Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) comprises 499 Chinese Pharmacopoeia-registered herbs and the structure information for 29,384 ingredients. In silico docking of these compounds into the P2Y1R protein structure within the MRS2500 pocket can identify potential antithrombotic drugs from natural medicinal plants. Docking studies were performed and scored to evaluate ligand-binding affinities. In this study, a total of 8987 compounds from Traditional Chinese Medicine (TCM) were filtered by Lipinski's rule of five, and their ideal oral-intake properties were evaluated. Of these, 1656 compounds distributed in 443 herbs docked into the P2Y1R-MRS2500 structure in 16,317 poses. A total of 38 compounds were ranked with a DockScore above 70, and these may have significant potential for development into anti-thrombosis drugs. These computational results suggested that licorice (Glycyrrhiza uralensis Fisch), cimicifugae (Cimicifuga foetida L.), and ganoderma (Ganoderma lucidum Karst) and their chemical constituents, which have not previously been widely used for anti-thrombosis, may have unexpected effects on platelet aggregation. Moreover, two types of triterpene scaffolds summarized from 10 compounds were distributed in these three herbs and also docked into P2Y1R. These scaffold structures may be utilized for the development of drugs to inhibit platelet aggregation.

Highlights

  • Cardiovascular disease (CVD) is the leading cause of mortality worldwide

  • From the 29,384 native Traditional Chinese Medicine (TCM) compounds collected from the TCMSP database, 8987 compounds were filtered by Lipinski’s rule of five and prepared for further study

  • Successful docking to P2Y1 receptor (P2Y1R) was observed for 1656 compounds (16,317 poses), and their ADME/T descriptors were calculated (Figure 2, Supplementary Datasheet 1)

Read more

Summary

Introduction

Cardiovascular disease (CVD) is the leading cause of mortality worldwide. CVD is multifactorial, and its risk factors include stroke, hypertension, arrhythmias, and thrombosis (Mozaffarian et al, 2016). Platelet aggregation-induced thrombosis obstructs blood circulation, playing a central role in acute, and chronic arterial vascular diseases (Radomski et al, 2005). Antiplatelet drugs decrease thrombus formation, and their estimated market is worth 24 billion United States dollars (USD). G protein-coupled P2Y receptors belong to the nucleotide receptor G protein-coupled receptor (GPCR) family and have eight mammalian subtypes (P2Y1,2,4,6,11-14) (Kim et al., 2003). P2Y1 and P2Y12 belong to the human purinergic GPCRs and can be activated by adenosine 5′-diphosphate (ADP) to induce platelet activation (Gurbel et al, 2015)

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.